MedPath

Treatment of patients with MRSA bacteria in their throat by irrigation with the drug mupiroci

Phase 1
Conditions
Patientents being MRSA positive for a minimum of 6 months and concluded at least one konventional topical treatments unsuccessfully
MedDRA version: 20.0Level: PTClassification code 10061554Term: Staphylococcal pharyngitisSystem Organ Class: 10021881 - Infections and infestations
Therapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]
Registration Number
EUCTR2014-005308-12-DK
Lead Sponsor
Region Sjælland, Slagelse Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

MRSA positive for a minimum of 6 months
Completed at least one conventional topical treatments without success.
18 years of age or above and able to consent
The S.aureus isolat is mupirocin sensitive

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 10
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 10

Exclusion Criteria

Sufforing from acute or chronic ilness in the ear, nose or throat
Sensitive to mupirocin
Risk of re-infection from environment (work, living conditions - eg work or living at a pig farm)
Negative

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: Aim<br>•To investigate whether nasopharyngeal carriers of MRSA are decolonised for MRSA by combining the konventional topical MRSA reatment with rhinopharynx irrigation with mupirocin <br><br>;Secondary Objective: To investigate if the treatment regimen can be used as first line tratment in newly diagnosed patients carrying MRSA in their throat ;Primary end point(s): Free of MRSA after 1 month (plus/minus 1 week), and free of MRSA after a minimum of 6 months;Timepoint(s) of evaluation of this end point: 1 month and 6 months
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): Same;Timepoint(s) of evaluation of this end point: 1 month and 6 months
© Copyright 2025. All Rights Reserved by MedPath